Le Wang, MD

34% fewer Medicare Part D claims than the average hematology (internal medicine) physician in 2024

327 Medicare Part D claims for 114 beneficiaries, against an average of 496 among the 1,036 providers of this specialty who prescribed in Part D. Brand-name drugs were 28% of claims. 12 claims were for opioids.

Most prescribed

1. Prochlorperazine Maleate42 claims
2. Dexamethasone35 claims
3. Letrozole26 claims
4. Eliquis25 claims
5. Bicalutamide11 claims
6. Nubeqa11 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 89.8 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $468.20

13 payments; by number, the most common kind was food and beverage; the largest payer was Exelixis Inc. The 721 providers of this specialty with any payment received $13,778.35 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

2 hospitals and group practices

1. Reading HospitalPhoenixville, PA · Acute Care Hospitals4 of 5 stars
2. Guthrie Medical Group PCSayre, PA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.